Xiang Guang-da
11
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
73%
8 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
The Therapeutical Role of Continuous Intra-femoral Artery Infusion of Urokinase on Diabetic Foot Ulcers
Role: lead
GLP-1 Agonism Stimulates Browning of Subcutaneous White Adipose Tissue in Obesity Men
Role: lead
Sildenafil Activates Browning of White Adipose and Improves Insulin Sensitivity
Role: lead
Chronic Cold Acclimation Stimulates the Browning of Subcutaneous White Adipose in Patients With Type 2 Diabetes Mellitus
Role: lead
Metformin Induces a Dietary Restriction-like State in Human
Role: lead
Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease
Role: lead
The Effect of Contrast Agent on Endothelial Function in Healthy Men
Role: lead
Cold Stress Stimulate the Browing of Subcutaneous White Adipose in Healthy Adults
Role: lead
Impact of Cardiac Magnetic Resonance Imaging on Endothelial Function in Type 2 Diabetes
Role: lead
Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes
Role: lead
The Effect of Intensive Multifactorial Therapy on Endothelial Function in Newly Diagnosed Type 2 Diabetes
Role: lead
All 11 trials loaded